about
Depression with pain co morbidity effect on quality of life among HIV positive patients in Uganda: a cross sectional study.Prevalence and associated factors of attention deficit hyperactivity disorder (ADHD) among Ugandan children; a cross-sectional study.Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.The frequency and precipitating factors for breakthrough seizures among patients with epilepsy in UgandaMalariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial.Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated MalariaGlobal medical education partnerships to expand specialty expertise: a case report on building neurology clinical and research capacityKnowledge, attitudes and perceptions of stroke: a cross-sectional survey in rural and urban UgandaPoor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional studyMultiple anti-epileptic drug use in children with epilepsy in Mulago hospital, Uganda: a cross sectional study.Prevalence and incidence of neurological disorders among adult Ugandans in rural and urban Mukono district; a cross-sectional study.Knowledge and Attitudes of Parkinson's Disease in Rural and Urban Mukono District, Uganda: A Cross-Sectional, Community-Based Study.Community knowledge of and attitudes toward epilepsy in rural and urban Mukono district, Uganda: A cross-sectional study.Post-stroke depression among stroke survivors attending two hospitals in Kampala UgandaNeuromyelitis optica in a Ugandan woman: a case report.Influence of Dietary Salt Knowledge, Perceptions, and Beliefs on Consumption Choices after Stroke in Uganda.Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda.Influence of sodium consumption and associated knowledge on poststroke hypertension in Uganda.A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.Modifiable lifestyle risk factors for stroke among a high risk hypertensive population in Greater Kampala, Uganda; a cross-sectional study.Prevalence, severity and factors associated with peripheral neuropathy among newly diagnosed diabetic patients attending Mulago hospital: a cross-sectional study.Feasibility study of a targeted self-management intervention for reducing stroke risk factors in a high-risk population in Uganda.Prevalence and factors associated with sleep disorders among children with cerebral palsy in Uganda; a cross-sectional study.Epilepsy misconceptions and stigma reduction interventions in sub-Saharan Africa, a systematic reviewKnowledge and attitudes about sudden death in epilepsy among people living with epilepsy and their healthcare providers in Mulago Hospital, Uganda: A cross-sectional studyVogt-Koyanagi-Harada Syndrome in a Ugandan: Diagnostic and Therapeutic ChallengesBarriers to epilepsy care in Central Uganda, a qualitative interview and focus group study involving PLWE and their caregivers
P50
Q30383039-5940A384-AA88-4C56-B434-3B77EE7DA9D9Q33564385-56A47C1D-3935-4334-9EDF-412D783BD2ECQ33841812-9C907E4F-E781-4EEC-990B-55C12A55121FQ34465308-2E68912A-2E26-4504-B3A4-5303344620DDQ34515124-87D27EA5-B0B4-4AE2-85AD-7E5184C33913Q35532952-A66C9F23-6E50-4E8E-8FAA-CF5DC8572402Q35535335-0AC83344-EDFF-4F1C-BE09-4FF4B5723C78Q35879109-38CECDE1-540E-4EDA-9A8B-EE36BB624333Q35883483-4F7C8B75-7AEB-48FE-8024-75D9BEA8540EQ35951765-9952F157-1EBA-43DA-9230-F007FD7E7C56Q36195363-1576CD74-FCAD-4EFC-9231-6CBA6572F4FBQ36356609-EEC91D3A-8D75-4E00-B965-4E4909482F06Q36495045-B06987E4-60C5-47E6-967B-09C4A234ABEBQ36612685-9EE95A44-DF1C-4C67-895C-018A97E1C68DQ37003931-03B7452E-61CB-4CC8-9D95-98C7928EFF2CQ38849272-A26A01B3-97EA-4FE8-BEAF-11DBF6F153E8Q38849331-2F0A1BCB-AD87-4480-8F46-3812D8DFD781Q38853269-C2DD08D1-1A3C-40C3-802F-8DDE911E9E34Q38853596-FA6BB36A-0698-4815-A4D3-8E6091AC393EQ38868907-648EAAC9-A456-4722-A7E3-34A6740CF04AQ38871071-1BB01D1E-9C16-44D5-A652-B35C223E05AFQ38880703-258D3A49-1B1F-4625-8BDF-603B30A81FCEQ47096289-C72D71D7-567F-4D8C-939B-0D711373A7CAQ47734657-0C3CD3A2-92B5-4CA0-B927-BAD3408CF65BQ50180317-89DAC905-8CE4-480A-BF7A-173200FE8A42Q50334613-61260A4F-DCF5-48FE-BC92-CB1E32F9DEA3Q56910854-199882B6-0211-42DE-9B4D-D254D4772AD5Q90095487-714278CD-0167-4652-B58F-A841F22A0AE4Q90861144-B0F518C9-9111-4272-BBE0-84BEA7D437D7Q91964469-8DB04763-0567-42E9-8B69-96052E8DD0D3
P50
description
researcher ORCID ID = 0000-0001-7390-7330
@en
wetenschapper
@nl
name
Mark Kaddumukasa
@ast
Mark Kaddumukasa
@en
Mark Kaddumukasa
@es
Mark Kaddumukasa
@nl
type
label
Mark Kaddumukasa
@ast
Mark Kaddumukasa
@en
Mark Kaddumukasa
@es
Mark Kaddumukasa
@nl
prefLabel
Mark Kaddumukasa
@ast
Mark Kaddumukasa
@en
Mark Kaddumukasa
@es
Mark Kaddumukasa
@nl
P21
P31
P496
0000-0001-7390-7330